Understanding the Point of Care Revolution

Of all the changes caused by the COVID-19 pandemic, the evolution of POC and home testing is perhaps the biggest. CLP Director of Business Intelligence Chris Wolski and Hamid Erfanian, CEO of Enzo Biochem, an integrated healthcare company focused on offering life sciences, including reagents, clinical testing and molecular diagnostic products, do a deep dive on the history of POC testing, how and why it became ubiquitous during COVID-19, and what this ubiquity means for the future of the clinical laboratory.